Is Regeneron Pharmaceuticals, Inc. overvalued?

Regeneron Pharmaceuticals, Inc. (REGN) looks undervalued — trading about 22% below its fair value.

Undervalued

Price

$632.90

Fair value

$773.52

Current P/E

15.3

Normal P/E

18.6

Market cap

$65.20B

Dividend yield

0.5%

Return on equity

14.4%

Sector

Healthcare

Fair value compares REGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks